Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT01858493
Status:
COMPLETED
Last Update Posted:
2017-07-24
First Post:
2013-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Continence Across Continents to Upend Stigma and Dependency
Sponsor:
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Organization:
Study Overview
Official Title:
Phase 3 Cluster Randomised Trial Testing the Efficacy of a Continence Promotion Intervention to Improve Urinary Symptoms and Quality of Life, and Reduce Stigma and Falls in Older Community-dwelling Women With Untreated Incontinence
Status:
COMPLETED
Status Verified Date:
2017-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CACTUS-D
Brief Summary:
To determine whether women exposed to the continence promotion intervention will report improved urinary symptoms and quality of life, and lower incontinence-related stigma and falls than women who receive a control intervention at one-year post-intervention.
Detailed Description:
This is a cluster-randomized 4-site intervention study testing the effect of a continence-promotion intervention on:
1. Improved urinary symptoms and quality of life
2. Reduction in falls
3. Reduction in stigma
A cost-effectiveness component will also be included
1. Improved urinary symptoms and quality of life
2. Reduction in falls
3. Reduction in stigma
A cost-effectiveness component will also be included
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: